Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Medpace Holdings Inc (MEDP) – Medpace Holdings Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Medpace Holdings (MEDP) trades at $419.75, showing modest daily gains but facing significant technical headwinds with a bearish moving average signal. The company demonstrates strong fundamental performance with consistent earnings beats, robust profitability metrics (ROE 77.25%, Net Margin 17.19%), and positive revenue growth projections. However, the stock faces substantial sentiment pressure from multiple securities class action lawsuits alleging fraud related to cancellation rates and backlog deterioration, contributing to recent volatility.
While MEDP's operational fundamentals remain solid with improving cash flow projections for 2026, investment outlook is clouded by legal risks and technical weakness. The stock trades below analyst consensus target of $465, offering potential upside if legal concerns resolve favorably, but faces near-term resistance at $422-$427. Key risks include litigation outcomes, potential financial settlements, and maintaining growth amid competitive CRO market pressures.
Read full analysis

Key Stats

  • Market Cap
    $12.10B
  • Sector
    Technology
  • 3M Drawdown
    -25.55%
  • Enterprise Value
    $11.57B
  • Dividend Yield
    -
  • Typical Hold Time
    5 days
$425
52W Low: $291.73
14 May 2025
52W High: $620.59
21 Jan 2026

Medpace Holdings Inc (MEDP) is currently valued at a market capitalization of $12.10B, with an enterprise value of $11.57B. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $291.73 and a high of $620.59, highlighting its annual price range. Over the past three months, Medpace Holdings Inc has recorded a drawdown of -25.55%, reflecting recent price volatility. On average, investors hold Medpace Holdings Inc for approximately 5 days, indicating typical investor behavior on the platform.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.


Technical Indicators
|
|
|
Overall Summary
Bearish (8)Neutral (7)Bullish (12)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $12.10B
  • Sector
    Technology
  • 3M Drawdown
    -25.55%
  • Enterprise Value
    $11.57B
  • Dividend Yield
    -
  • Typical Hold Time
    5 days
$425
52W Low: $291.73
14 May 2025
52W High: $620.59
21 Jan 2026

Medpace Holdings Inc (MEDP) is currently valued at a market capitalization of $12.10B, with an enterprise value of $11.57B. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $291.73 and a high of $620.59, highlighting its annual price range. Over the past three months, Medpace Holdings Inc has recorded a drawdown of -25.55%, reflecting recent price volatility. On average, investors hold Medpace Holdings Inc for approximately 5 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!